Royal Bank Of Canada Kaleido Biosciences, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $68 - $2,322	-1,366 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $2.7 $5,148 - $10,692	-3,960 Reduced 74.35%	1,366 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $4,846 - $12,208	2,028 Added 61.49%	5,326 $12,000
Q3 2021 Nov 15, 2021	BUY	$5.36 - $7.99 $6,410 - $9,556	1,196 Added 56.9%	3,298 $18,000
Q2 2021 Aug 16, 2021	BUY	$5.82 - $8.72 $12,233 - $18,329	2,102 New	2,102 $15,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.